Quick Answer
Verrica Pharmaceuticals Inc. reported Total Assets of $47.13 million for fiscal year 2025.
Verrica Pharmaceuticals Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $47.13M | -12.9% |
| 2024 | $54.13M | -33.7% |
| 2023 | $81.60M | +82.5% |
| 2022 | $44.72M | -44.2% |
| 2021 | $80.12M | +8.1% |
| 2020 | $74.15M | +8.4% |
| 2019 | $68.42M | -25.6% |
| 2018 | $91.91M | +911.8% |
| 2017 | $9.08M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $40.90M | +24.2% | +4.6% |
| June 30, 2025 | $39.11M | -24.8% | -7.3% |
| March 31, 2025 | $42.18M | -36.4% | -22.1% |
| December 31, 2024 | $54.13M | -33.7% | +64.4% |
| September 30, 2024 | $32.93M | -66.1% | -36.7% |
| June 30, 2024 | $52.01M | -16.4% | -21.6% |
| March 31, 2024 | $66.31M | -3.4% | -18.7% |
| December 31, 2023 | $81.60M | +82.5% | -16.0% |
- Verrica Pharmaceuticals Inc. showed a decrease of -12.9% in Total Assets compared to the prior fiscal year.
- Over the 2017–2025 period, Verrica Pharmaceuticals Inc.’s total assets has grown by 418.9% (from $9.08 million to $47.13 million).
- The most recent figure is from Verrica Pharmaceuticals Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 11, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: